These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 973932)
1. Proceedings: Significance of cycle length alternation during drug treatment of supraventricular tachycardia. Curry PV; Krikler DM Br Heart J; 1976 Aug; 38(8):882. PubMed ID: 973932 [No Abstract] [Full Text] [Related]
2. Cycle length alternation in supraventricular tachycardia after administration of verapamil. Vohra J; Hunt D; Stuckey J; Sloman G Br Heart J; 1974 Jun; 36(6):570-6. PubMed ID: 4851237 [No Abstract] [Full Text] [Related]
3. [Effect of verapamil on retrograde conduction in ventricular tachycardia. Description of a case]. Cavallini B; Spinolo L; Bosi S; Piancastelli M Minerva Cardioangiol; 1984 Apr; 32(4):231-3. PubMed ID: 6462474 [No Abstract] [Full Text] [Related]
4. Verapamil effects on retrograde conduction in supraventricular tachycardia therapy. Aryanpur-Kashani I Am Heart J; 1982 Feb; 103(2):306-8. PubMed ID: 7055066 [No Abstract] [Full Text] [Related]
5. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Rowland E; McKenna WJ; Gülker H; Krikler DM Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649 [TBL] [Abstract][Full Text] [Related]
6. [Use of non-invasive transdermal stimulation of the heart in selecting an anti-arrhythmia drug in a patient with supraventricular paroxysmal tachycardia with a re-entry mechanism within the atrioventricular node]. Prochaczek F; Gałecka J; Becker A Kardiol Pol; 1988; 31(6):337-42. PubMed ID: 3236620 [No Abstract] [Full Text] [Related]
7. [The phenomenon of accelerated A-V conduction. Electrophysiological study with a "selective" calcium antagonist (Verapamil)]. Disertori M; Vergara G; Cozzi F; Inama G; Furlanello F G Ital Cardiol; 1981; 11(4):447-57. PubMed ID: 7286518 [TBL] [Abstract][Full Text] [Related]
8. [Effect of verapamil on the electrophysiological properties of the atrioventricular node in patients with atrioventricular nodal tachycardia]. Molenda W; Telichowski C; Korcz S; Banasiak W; Petruk J Kardiol Pol; 1987; 30 Suppl():87-91. PubMed ID: 3331402 [No Abstract] [Full Text] [Related]
9. Clinical experience with verapamil. Vohra J; Hunt D; Sloman G Med J Aust; 1975 Sep; 2(11):417-21. PubMed ID: 1186549 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of termination of reentrant atrioventricular nodal paroxysmal supraventricular tachycardia by intravenous verapamil--an intracardiac electrophysiologic study. Shankar SJ; Sethi KK; Khalilullah M Indian Heart J; 1983; 35(1):8-18. PubMed ID: 6852846 [No Abstract] [Full Text] [Related]
11. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Klein V; Repke JT Obstet Gynecol; 1984 Mar; 63(3 Suppl):16S-18S. PubMed ID: 6700874 [TBL] [Abstract][Full Text] [Related]
12. [Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment]. González R; Fajuri A; Arriagada C; Marchesse M; Serrat H Rev Med Chil; 1989 Apr; 117(4):440-4. PubMed ID: 2519400 [TBL] [Abstract][Full Text] [Related]
13. [Effect of verapamil on electrocardiographic rhythm disorders. Clinical and experimental results]. Chapelle M; Benaim R; Chiche P; Cabrol C; Cabrol A Therapie; 1973; 28(4):689-701. PubMed ID: 4602479 [No Abstract] [Full Text] [Related]
14. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Epstein ML; Kiel EA; Victorica BE Pediatrics; 1985 Apr; 75(4):737-40. PubMed ID: 3982906 [TBL] [Abstract][Full Text] [Related]
15. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias]. Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253 [TBL] [Abstract][Full Text] [Related]
16. [Feasibility of combination mapping utilizing a duo-decapolar electrode catheter and the CARTO system for incisional reentrant atrial tachycardia with cycle length alternation: a case report]. Sohara H; Tanaka K; Ishigaki K; Yamaguchi Y; Murakami M; Takahashi S; Taketani Y; Sunami K; Miyashita Y; Hiroe Y; Tanaka S; Saito S; Satake S; Watanabe Y J Cardiol; 2003 Mar; 41(3):135-42. PubMed ID: 12674998 [TBL] [Abstract][Full Text] [Related]
17. The prophylaxis of AV nodal re-entry tachycardia. Tonkin AM; Shorne L Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of short- and long-term verapamil therapy in children with tachycardia. Sapire DW; O'Riordan AC; Black IF Am J Cardiol; 1981 Dec; 48(6):1091-7. PubMed ID: 6795914 [No Abstract] [Full Text] [Related]
19. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway]. Finzi A; Potenza S; Guenzati G G Ital Cardiol; 1990 Dec; 20(12):1161-7. PubMed ID: 2128068 [TBL] [Abstract][Full Text] [Related]
20. Verapamil and ventricular tachycardias. Tai YT; Chow WH; Lau CP; Yau CC Chin Med J (Engl); 1991 Jul; 104(7):567-72. PubMed ID: 1879219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]